Tissue Regenix Group plc (LON:TRX – Get Free Report)’s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 63.95 ($0.84) and traded as low as GBX 58.50 ($0.77). Tissue Regenix Group shares last traded at GBX 60 ($0.79), with a volume of 33,017 shares.
Tissue Regenix Group Stock Down 1.6 %
The firm’s 50-day moving average price is GBX 63.87 and its 200 day moving average price is GBX 63.95. The firm has a market cap of £42.74 million, a P/E ratio of -6,000.00 and a beta of 1.62. The company has a quick ratio of 2.36, a current ratio of 4.03 and a debt-to-equity ratio of 32.01.
Tissue Regenix Group Company Profile
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of bone graft substitutes and soft tissue in the United States and internationally. The company operates through dCELL, BioRinse, and GBM-V segments. It also provides dCELL technology, a soft tissue decellularisation process that removes DNA and other cellular material from animal and human soft tissue to repair diseased or damaged body parts; and BioRinse technology, a natural bone filler solution for osteoinductivity to stimulate and regenerate native bone growth.
See Also
- Five stocks we like better than Tissue Regenix Group
- How to Use Stock Screeners to Find Stocks
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- 10 Best Airline Stocks to Buy
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- How to Invest in Insurance Companies: A Guide
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.
